COVID-19 mRNA Vaccine-Associated Myocarditis Presenting as STEMI in a 48-Year-Old Male | Zendy

Mohammad Dlewati | Zendy; Kyeeun Park | Zendy; Saumya Rawat | Zendy; Jorge Conte | Zendy; Kashmira Bhadha | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

COVID-19 mRNA Vaccine-Associated Myocarditis Presenting as STEMI in a 48-Year-Old Male

Author(s) -

Mohammad Dlewati,

Kyeeun Park,

Saumya Rawat,

Jorge Conte,

Kashmira Bhadha

Publication year - 2022

Publication title -

case reports in cardiology

Language(s) - English

Resource type - Journals

eISSN - 2090-6412

pISSN - 2090-6404

DOI - 10.1155/2022/2284530

Subject(s) - medicine , myocarditis , covid-19 , viral myocarditis , vaccination , etiology , chest pain , cardiology , complication , incidence (geometry) , disease , cardiac catheterization , immunology , infectious disease (medical specialty) , physics , optics

Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) mRNA vaccinations. Young adult and adolescent males < 30 years of age are the most commonly affected group, with decreased incidence with older age. This is a case of a 48-year-old male who presented with chest pain and EKG findings of STEMI shortly after receiving the second dose of the Moderna COVID-19 mRNA vaccine. Emergent left heart catheterization revealed normal coronaries. Subsequently, the patient had rapid resolution of his symptoms and improvement in serum markers. The exact etiology factors to this new and rare phenomenon are yet to be fully understood. This patient did have a history of previous viral myocarditis 7 years ago; however, it remains unclear if this could be a predisposing factor to the development of mRNA vaccine-associated myocarditis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research